Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women.

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Abstract Text:

Jun Wang,Russell Higuchi,Francesmary Modugno,Jia Li,Nanette Umblas,Jocelyn Lee,Li-Yung Lui,Elad Ziv,Jeffery A Tice,Steven R Cummings,Brian Rhees,Jun Wang,Russell Higuchi,Francesmary Modugno,Jia Li,Nanette Umblas,Jocelyn Lee,Li-Yung Lui,Elad Ziv,Jeffery A Tice,Steven R Cummings,Brian Rhees,

Life-long exposure to estrogen is an established risk factor for breast cancer development. The underlying mechanism has been suggested to be the binding of estrogen-to-estrogen receptors in mammary tissue, which in turn promotes the proliferation and differentiation of breast tissue. Polymorphisms and haplotypes in estrogen receptor alpha (ESR1) have been reportedly associated with breast cancer risk; however, the results are not fully consistent. In this study, we investigated breast cancer risk associated with genotypes and haplotypes resulting from four ESR1 single nucleotide polymorphisms (SNPs), rs746432, rs2234693, rs9340799, and rs1801132. Genotyping has been performed on 393 breast cancer cases and 790 randomly selected controls in 1,183 Caucasian women over age 65 from the Study of Osteoporotic Fractures (SOF). We observed an allelic protective effect for SNP rs9340799 with an estimated odds ratio (OR) of 0.82 (95% CI = 0.68-1.00; P = 0.04) after adjustment for age, BMI and hip BMD. A protective effect of this SNP has been reported before in several different studies. We did not replicate the previously reported C-C-A-G haplotype association to breast cancer-the C-C-A-G haplotype from these SNPs was rare in this study (estimated frequency below 0.001% in cases and controls). No other statistically significant associations were observed between ESR1 haplotypes from the same four SNPs and the risk of breast cancer in older Caucasian women.

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Publishing Authors By Initials

J Wang,R Higuchi,F Modugno,J Li,N Umblas,J Lee,LY Lui,E Ziv,JA Tice,SR Cummings,B Rhees,J Wang,R Higuchi,F Modugno,J Li,N Umblas,J Lee,LY Lui,E Ziv,JA Tice,SR Cummings,B Rhees,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Breast cancer research and treatment

VOLUME: 106

Page Numbers: 273-80

Journal Abbreviation: Breast Cancer Res. Treat.

ISSN: 0167-6806

DAY: 1

MONTH: 02

YEAR: 2007

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8111104

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women.

AFFILIATION: Human Genetics Department, Roche Molecular Systems, Inc., 1145 Atlantic Ave, Alameda, CA, 94555, USA, jun.wang@roche.com.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Breast Cancer Res Treat

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women Related Publications

• Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women.